The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance

Heart

Volumn 96, Issue 17, 2010, Pages 1390-1395

  Jakovljevic, Djordje G ^a,b   George, Robert S ^c,d   Nunan, David ^e   Donovan, Gay ^b   Bougard, Robert S ^c   Yacoub, Magdi H ^d   Birks, Emma J ^c,d,f   Brodie, David A ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BUCKINGHAMSHIRE NEW UNIVERSITY   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d Heart Science Centre   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA VALVE; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; EXERCISE; HEART ASSIST DEVICE; HEART FUNCTION; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART PERFORMANCE; HEART PRELOAD; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REBREATHING; COMPLICATION; CONGESTIVE CARDIOMYOPATHY; EVALUATION STUDY; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HYPERTROPHIC CARDIOMYOPATHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; CARDIAC OUTPUT; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PULMONARY GAS EXCHANGE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956118046     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.193698     Document Type: Article

References (36)

1. Badiwala MV, Rao V. Left ventricular device as destination therapy: are we there yet? Curr Opin Cardiol 2009;24:184-9.
2. Birks EJ, Yacoub MH, Banner NR, et al. The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol 2004;19:148-53.
3. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Eng J Med 2006;355:1873-84.
4. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovas Surg 2001;122:1186-95.
5. Hetzer R, Müller JH, Weng Y, et al. Bridging-to-recovery. Ann Thorac Surg 2001;71(Suppl III):S109-13.
6. John R, Kamdar F, Liao K, et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227-34; discussion 34-5.
7. Lahpor J, Khaghani A, Hetzer R, et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010;37:357-61.
8. Long JW, Kfoury AG, Slaughter MS, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Cong Heart Fail 2005;11:133-8.
9. Miller LW, Pagani FD, Russell SD, et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Eng J Med 2007;357:885-96.
10. Stevenson LW, Miller LW, Desvigne-Nickens P, et al; REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004;110:975-81.
11. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21.
12. Dandel M, Weng Y, Siniawski H, et al. Long term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005;112(Suppl 9):I37-45.
13. Maybaum S, Mancini D, Xydas S, et al. LVAD Working Group. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115:2497-505.
14. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using venricular assist devices: prevalance, clinical characteristics, and outcomes. Circulation 2005;112(Suppl 9):I32-6.
15. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
16. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 2001;22:534-40.
17. Griffith BP, Kormos RL, Borovetz HS, et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001;71(Suppl III): S116-S20.
18. Agostoni P, Cattadori G, Apostolo A, et al. Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 2005;46:1779-81.
19. Jakovljevic DG, Nunan D, Donovan G, et al. Comparison of cardiac output determined by different rebreathing methods at rest and at peak exercise. Eur J Appl Physiol 2008;102:593-9.
20. Cooke GA, Marshall P, Al-Timman JK, et al. Physiological cardiac reserve: development of a non-invasive method and first estimates in man. Heart 1998;79:289-94.
21. George RS, Yacoub MH, Tasca G, et al. Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery. J Heart Lung Transplant 2007;26:967-73.
22. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383-9.
23. Myers TJ, Frazier OH, Mesina HS, et al. Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant 2006;25:379-83.
24. Maybaum S, Stockwell P, Naka Y, et al. Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report. J Heart Lung Transplant 2003;22:202-9.
25. Slaughter MS, Silver MA, Farrar DJ, et al. A new method of monitoring recovery and weaning the Thoratec left ventricular assist device. Ann Thorac Surg 2001;71:215-18.
26. Ferrari M, Kadipasaoglu KA, Croitoru M, et al. Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant 2005;24:226-8.
27. George RS, Sabharwal NK, Webb C, et al. Echocardiographic evaluation of flow across HeartMate II axial flow LVADs at varying low speeds. J Heart Lung Transplant 2009;28:2S.
28. Farrar DJ, Holman WR, McBridge LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21:516-21.
29. Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet 1986;13:1360-3.
30. Tan LB. Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure. Cardiovasc Res 1987;21:615-22.
31. Tan LB, Bain RJ, Littler WA. Assessing cardiac pumping capability by exercise testing and inotropic stimulation. Br Heart J 1989;62:20-5.
32. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the shock trial registry. J Am Coll Cardiol 2004;44:340-8.
33. Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 2007;153:366-70.
34. Roul G, Moulichon ME, Bareiss P, et al. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 1995;16:1387-98.
35. Tan LB, Littler WA. Measurement of cardiac reserve in cardiogenic shock: implication for prognosis and management. Br Heart J 1990;64:121-8.
36. Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output: a indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22:1496-503.